OTC - ACTIVE INGREDIENT SECTION
glycerin
glycerin
palm oil, ginkgo leaf ext, aloe ext, menthol, jojoba oil, zeolite, red ginseng ext, pine ext, orange oil etc
strengthen blood circulation function
deodorant
anti-microbial
strengthen sexual function
keep out of reach of the children
Foaming using a shower towel
Massage evenly to the 10cm above the knee to 50cm below the navel using the foaming shower towel
Furl in the important part by the shower towel and wait for about 2~3 minutes with giving strength to the hip repeating tightening and loosening 10 ~ 15 seconds
wash out with cool water
do not swallow
for topical use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69196-1001-1 | 2024-07-30 | C162847 | 48780-1 | f386c649-a668-0266-e053-dadaa90a7c1a | Niagara S 69196-1001-1 |
| 69196-1001-1 | 2024-01-30 | C162847 | 48780-1 | f386c649-a668-0266-e053-dadaa90a7c1a | Niagara S 69196-1001-1 |
| 69196-1001-1 | 2023-01-31 | C162847 | 48780-1 | f386c649-a668-0266-e053-dadaa90a7c1a | Niagara S 69196-1001-1 |
| 69196-1001-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-a668-0266-e053-dadaa90a7c1a | Niagara S 69196-1001-1 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69196-1001-1 | Niagara S | 70 g in 1 PACKAGE | SOAP | 70 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69196-1001 | NIAGARA S (GLYCERIN) SOAP [SUNGWON COSMETICS] | 5 | Legacy NDC, 1 package rows | 20230202_7cce7eff-da2f-4333-8cd8-fa4ff7db773e.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 3 | |
| ALOE | INACTIVE INGREDIENT | V5VD430YW9 | 3 | |
| GINKGO | INACTIVE INGREDIENT | 19FUJ2C58T | 3 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69196-1001 | 69196-1001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GINKGO | 19FUJ2C58T | IACT |
| ALOE | V5VD430YW9 | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MENTHOL | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION, CONCENTRATE / ORAL | 0.5 mg/1ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | JELLY / NASAL | 32.5 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SYRUP / ORAL | 7.5 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / DENTAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SUSPENSION / ORAL | 1 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f39be985-f473-fa84-e053-2a95a90a8cd9 | 7cce7eff-da2f-4333-8cd8-fa4ff7db773e | 2023-01-31 | Warnings | f39be985-f473-fa84-e053-2a95a90a8cd9 7cce7eff-da2f-4333-8cd8-fa4ff7db773e |
Adverse event summaries are temporarily unavailable. Other product information remains available.